Clinical guide to herb-drug interactions in oncology Journal Article


Authors: Yeung, K. S.; Gubili, J.
Article Title: Clinical guide to herb-drug interactions in oncology
Abstract: Cancer patients are increasingly using herbal supplements for relief of symptoms. However, there is a great potential for interactions with concurrent use of herbs and chemotherapy agents. Physicians should be aware of such interactions and encourage patients to discuss supplement use.
Keywords: clinical trial; review; angiogenesis inhibitor; bevacizumab; doxorubicin; antineoplastic agents; neoplasms; imatinib; unindexed drug; low drug dose; liver toxicity; pharmacodynamics; breast cancer; bleeding; prevalence; risk factors; clinical protocol; deep vein thrombosis; kidney failure; oncology; diet supplementation; irinotecan; lung embolism; drug distribution; warfarin; tamoxifen; platinum derivative; antioxidant; dietary supplements; herbaceous agent; ascorbic acid; traditional medicine; vinca alkaloid; herb drug interaction; drug absorption; taxane derivative; anthracycline derivative; turmeric; immunosuppressive agent; anticoagulant agent; drug elimination; vitamin k group; green tea extract; medicine, herbal; glycoprotein p; tea; herb-drug interactions; aristolochic acid; ginseng; silybum marianum extract; comfrey extract; hypericum perforatum extract; ginseng extract; chemotheraphy agents; herbal supplements; chamomile; furocoumarin; pyrrolizidine derivative; salvia miltiorrhiza extract; comfrey; coptis; kidney fibrosis; salvia miltiorrhiza
Journal Title: Journal of the Society for Integrative Oncology
Volume: 5
Issue: 3
ISSN: 1715-894X
Publisher: BC Decker  
Date Published: 2007-06-01
Start Page: 113
End Page: 117
Language: English
DOI: 10.2310/7200.2007.008
PUBMED: 17761130
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 5" - "Export Date: 17 November 2011" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Kwokwai Yeung
    36 Yeung
  2. Jyothirmai Gubili
    22 Gubili